The inferior survival of patients MYC+/BCL2+ and MYC+/BCL6+ DLBCL compared with all other DLBCL patients was significant for both the GCB and ABC subtypes, whereas BCL2+/BCL6+ only correlated with poorer OS for patients with ABC-DLBCL (Supplementary Figure S4). The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.